Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.
暂无分享,去创建一个
J. Bryant | N. Wolmark | E. Mamounas | B. Fisher | J. Wang | Jiping Wang | E. Mamounas | N. Wolmark
[1] H. Skipper,et al. Kinetics of mammary tumor cell growth and implications for therapy , 1971, Cancer.
[2] Goldie Jh,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .
[3] N Gunduz,et al. Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.
[4] J H Goldie,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979, Cancer treatment reports.
[5] G. Lesnick,et al. Chemotherapy before and after mastectomy in stage III breast cancer. , 1982, Archives of surgery.
[6] N Gunduz,et al. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.
[7] J. Butler,et al. Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer , 1983, Journal of surgical oncology.
[8] C. Redmond,et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.
[9] B Fisher,et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.
[10] A. Luini,et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.
[11] L. Mauriac,et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] Y. Bignon,et al. Neoadjuvant chemotherapy in 126 operable breast cancers. , 1992, European journal of cancer.
[13] F. Spyratos,et al. Preoperative chemotherapy of operable breast cancer (stage IIIA). Prognostic factors of distant recurrence , 1993 .
[14] M. Baum,et al. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. , 1993, European journal of cancer.
[15] B. Asselain,et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.
[16] T. Powles,et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] E. Mamounas,et al. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] E. Mamounas. NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel. , 1997, Oncology.
[19] D. Wickerham,et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Mamounas Ep. NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel , 1997 .
[21] Mamounas Ep. Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies. , 1998 .
[22] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[23] T. Powles,et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] E. Mamounas. Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies. , 1998, Seminars in oncology.
[26] Mike Clarke,et al. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .
[27] J. Vermorken. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.
[28] M. Bonetti,et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Ronin,et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, The New England journal of medicine.
[30] G Noël,et al. [Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.